PNC Financial Services Group
ACHN

PNC Financial Services Group’s Achillion Pharmaceuticals ACHN Stock Holding History

PNC Financial Services Group’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,000
Closed -$16K – 4153
2016
Q3 		$16K Sell
2,000
-16,351
-89% -$139K ﹤0.01% 3334
2016
Q2 		$143K Buy
18,351
+15,689
+589% +$135K ﹤0.01% 2281
2016
Q1 		$20K Buy
2,662
+23
+0.9% +$168 ﹤0.01% 3288
2015
Q4 		$29K Sell
2,639
-3,000
-53% -$27.3K ﹤0.01% 3115
2015
Q3 		$38K Sell
5,639
-5,779
-51% -$47.1K ﹤0.01% 3044
2015
Q2 		$101K Buy
11,418
+282
+3% +$2.67K ﹤0.01% 2641
2015
Q1 		$109K Hold
11,136
– – ﹤0.01% 2633
2014
Q4 		$136K Sell
11,136
-5,664
-34% -$69.2K ﹤0.01% 2298
2014
Q3 		$168K Buy
16,800
+16,000
+2,000% +$149K ﹤0.01% 2102
2014
Q2 		$6K Buy
+800
New +$3.19K ﹤0.01% 3287

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PNC Financial Services Group's ACHN Position: Q4 2016 in Review

PNC Financial Services Group sold out of Achillion Pharmaceuticals (ACHN) in Q4 2016, closing a stake of 2,000 shares — an estimated $16K sold.

PNC Financial Services Group first reported a position in ACHN in Q2 2014 and held it in 10 quarters. The position peaked at $168K in Q3 2014. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

  • PNC Financial Services Group reported no remaining Achillion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 2,000 Achillion Pharmaceuticals shares in Q4 2016, an estimated $16K.
  • PNC Financial Services Group first reported a position in Achillion Pharmaceuticals in Q2 2014 and held it in 10 quarters.
  • PNC Financial Services Group's Achillion Pharmaceuticals position peaked at $168K in Q3 2014.
  • 140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on PNC Financial Services Group's 13F filing for Q4 2016, filed 10 Feb 2017.